Quick Order Cart

Cat. No. ARG32751

KIAA1217 Knockout SK-HEP-1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Adenocarcinoma

KIAA1217 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population designed for loss-of-function analysis of CCDC57, a coiled-coil domain protein with potential roles in actin dynamics and Wnt signaling. The SK-HEP-1 line, an endothelial-like hepatocellular carcinoma model, provides a disease-relevant context for studying cytoskeletal remodeling. Targeted disruption of KIAA1217 may affect interactions with ??-catenin, FAK, and ??-tubulin, enabling research into cell motility, focal adhesion, and metastatic progression. Applications include RT-qPCR, western blotting, wound healing, transwell invasion, and RNA-seq experiments for liver cancer and musculoskeletal disease research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    SK-HEP-1

    Sex of Donor

    Male

    Age

    52 years

    Gene Name

    KIAA1217

    Gene Identifier

    NCBI Gene ID 56243

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KIAA1217 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population derived from SK-HEP-1, designed for loss-of-function studies of the KIAA1217 gene, which encodes coiled-coil domain-containing protein 57 (CCDC57). This heterogeneous knockout pool allows pooled functional screening while avoiding clonal biases. The model is optimized for investigating cytoskeletal organization, cell motility, and cancer-relevant signaling.

SK-HEP-1, the parental line, is an adherent, endothelial-like human hepatic adenocarcinoma cell line originating from ascites of a liver cancer patient. Known for its metastatic phenotype, it expresses endothelial markers and is a standard model for hepatocellular carcinoma (HCC) research. This background provides a context for examining gene functions related to tumor cell migration, invasion, and epithelial-mesenchymal transition.

KIAA1217/CCDC57 is a putative cytoskeletal organizer with coiled-coil domains that facilitate protein interactions. Potential interacting partners include ??-tubulin, ??-catenin, and focal adhesion kinase (FAK), linking it to Wnt and focal adhesion signaling. Representative pathway components such as RhoA and cofilin suggest that KIAA1217 disruption may impair actin dynamics, cell adhesion, and motility. Although upstream regulators remain unidentified, factors associated with mesenchymal transition are plausible candidates.

In SK-HEP-1 HCC models, KIAA1217 knockout provides a means to dissect the gene??s role in liver cancer progression. The interaction with ??-catenin and FAK situates this protein at a signaling hub frequently altered in HCC, potentially coordinating cytoskeletal rearrangements and adhesion. Moreover, associations with adolescent idiopathic scoliosis and disc degeneration imply broader functions in connective tissue biology, making this model relevant for studying both cancer and musculoskeletal disorders.

This knockout pool is suitable for RT-qPCR, western blotting, immunofluorescence, wound healing, transwell invasion, and RNA-seq experiments. Clonal isolation allows generation of isogenic lines for detailed mechanistic studies. Applications include functional analysis of disease-associated variants, high-throughput drug screening, and exploration of actin regulatory networks. For ordering and technical support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)